TSC Ratings provides exclusive stock, ETF and mutual fund recommendations using proprietary tools. Our "safety-first" approach aims to reduce risk while achieving performance on a total return basis.

The following fast-growth companies are projected to increase revenue and profits by at least 12% in the coming year and have received "buy" ratings from our proprietary quantitative model, which considers more than 60 factors. They are ordered by their potential to appreciate.

Strayer Education ( STRA) is a for-profit post-secondary education company that offers a variety of academic programs through Strayer University.

The numbers: First-quarter revenue increased 28% to $125 million as net income jumped 24% to $29 million and earnings per share improved 26% to $2.07. Operating margin improved to 38% as net margin fell 23%. Strayer has no debt and a quick ratio of 1.5, indicating an ideal financial position.

The stock: Strayer has fallen 5% in 2009, outperforming the Dow Jones Industrial Average and underperforming the S&P 500. The stock trades at a price-to-earnings ratio of 33 and offers a weak dividend yield of 1%.

National Presto Industries ( NPK) makes small appliances, and defense and absorbent products.

The numbers: First-quarter revenue increased 40% to $108 million as net income and earnings per share ascended 74% to $11 million and $1.58, respectively. Operating margin improved to 14% and net margin climbed to 10%. The company has no debt or interest expenses and abundant cash reserves, as reflected by a quick ratio of 3.6.

The stock: National Presto is up 5% in 2009, outperforming the Dow and S&P 500. The stock trades at a price-to-earnings ratio of 11 and pays a meager 1.3% dividend.

Teva Pharmaceuticals ( TEVA) is an Israeli company that develops and markets a range of generic and branded pharmaceuticals, biogenerics and active pharmaceutical ingredients.

The numbers: First-quarter revenue increased 22% to $3.1 billion as net income surged 225% to $451 million and earnings per share climbed 183% to 51 cents. Operating margin declined to 18% and net margin increased to 14%. The company has conservative leverage, as reflected by a debt-to-equity ratio of 0.5. But a quick ratio of 0.8 indicates a less-than-ideal liquidity position.

The stock: Teva is up 17% in 2009, outperforming the Dow and S&P 500. The stock trades at a price-to-earnings ratio of 48, indicating a significant premium to its peers, and offers a modest 1.2% dividend yield.

Quality Systems ( QSII) develops and markets health-care information systems that automate medical and dental practices and networks of practices.

The numbers: Fiscal fourth-quarter revenue ascended 28% to $66 million as net income inched up to $11.4 million and earnings per share fell 2% to 40 cents. Operating margin fell to 28% and net margin declined to 17%. The company has no debt or interest expenses and a strong cash balance, as reflected by a quick ratio of 2.1.

The stock: Quality Systems has climbed 23% in 2009, outperforming all major U.S. indexes. The stock trades at an expensive price-to-earnings ratio of 33 and pays a dividend yield of 2.3%.

Tyler Technologies ( TYL) provides information-technology services to local governments in the U.S., Canada, Puerto Rico and the U.K.

The numbers: First-quarter revenue increased 17% to $70 million as net income and earnings per share doubled to $6 million and 16 cents, respectively. Operating margin improved from 8% to 14% and net margin climbed from 5% to 9%. The cash balance has decreased 82% to $7.4 million since the year-earlier quarter. And a quick ratio of 0.6 is a sign of weak liquidity. However, the company has a light debt load, as indicated by just $7.5 million of long-term obligations and a debt-to-equity ratio just above zero.

The stock: Tyler Technologies has surged 36% in 2009, outperforming all major U.S. indexes. The stock trades at an expensive price-to-earnings ratio of 35 and doesn't pay dividends.

TSC Ratings was given an award for "Best Stock Selection" among independent research providers by BNY ConvergEx Group. A rating can be viewed for any stock through our screener. Each rating is derived from a variety of fundamental and pricing figures and represents our opinion of risk-adjusted performance relative to a 5,000+ stock coverage universe. However, the rating does not incorporate all factors that can alter a stock's performance, such as corporate or industry events, technology innovations and shifts in competitive dynamics.

More from Stocks

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

Novo Nordisk Stock Rises 4% Over 2 Sessions

Novo Nordisk Stock Rises 4% Over 2 Sessions

Stock Market Just Took Another Beating -- Here's What You Need to Know

Stock Market Just Took Another Beating -- Here's What You Need to Know

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

Daimler's Profit Warning Should Terrify Traders Before Earnings Season Begins

Daimler's Profit Warning Should Terrify Traders Before Earnings Season Begins